While neuroblastoma cells harboring ATRX mutations are thought to rely on ALT to maintain telomere lengths (18), a recent study has shown that neuroblastoma tumors can also be negative for both ALT and telomerase. This evidence concerns the gene GPT and neuroblastoma.